UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000013125
Receipt No. R000015308
Scientific Title A efficacy of maintenance intensification therapy by(Bevacizumab)/Pemetrexed/Carboplatin or Cisplatin after induction therapy by Erlotinib for EGFR mutation positive non -spuamous non-small cell lung cancer.
Date of disclosure of the study information 2014/02/10
Last modified on 2019/08/21 20:53:56

No. Disposal Last modified on Item of update
1 Insert 2014/02/10 19:36:10
2 Update 2014/02/12 09:14:16 Recruitment status
3 Update 2014/02/12 09:14:58 UMIN ID1
4 Update 2014/06/23 17:21:12 Recruitment status
5 Update 2016/03/17 15:00:24 Organization1
Email1
6 Update 2019/08/21 20:35:42 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
7 Update 2019/08/21 20:49:14 Recruitment status
Date of IRB
Anticipated trial start date
Last follow-up date
8 Update 2019/08/21 20:53:56 Number of participants that the trial has enrolled


Contact us.